Antidepressant properties of 2-(4-ethyl-1-piperazinyl)-4-phenylquinoline hydrochloride (AD-1308) and its mechanism of action as compared with tricyclic antidepressants.
D000374:Aggression / Q000187:drug effects; D000818:Animals; D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D001923:Brain Chemistry; D003000:Clonidine / Q000494:pharmacology; D004569:Electroencephalography; D005260:Female; D000882:Haplorhini; D006633:Histamine Antagonists; D006801:Humans; D008252:Macaca fascicularis; D008297:Male; D051379:Mice; D009474:Neurons / Q000187:drug effects; D010095:Oxotremorine / Q000494:pharmacology; D010276:Parasympatholytics; D011804:Quinolines / Q000494:pharmacology*; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors; D013747:Tetrabenazine / Q000037:antagonists & inhibitors
D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic; D006633:Histamine Antagonists; D010276:Parasympatholytics; D011804:Quinolines; D010095:Oxotremorine; C026400:AD 1308; D012110:Reserpine; D003000:Clonidine; D013747:Tetrabenazine